Gene Panel Market Size, Share, and Industry Analysis By Type (Services and Products), By Technology (Amplicon Sequencing and Hybridization Capture), By Application (Neurology, Oncology, Cardiology, and Others), By End User (Pharma and Biotech Companies, Research and Academic Institutes, and Others), and Regional Forecast, 2026-2034

The global gene panel market size was valued at USD 3.92 billion in 2025. The market is projected to grow from USD 4.62 billion in 2026 to USD 17.18 billion by 2034, exhibiting a CAGR of 17.85% during the forecast period.

The global gene panel market is experiencing significant expansion. It is attributed to growing prevalence of hereditary disorders and rising requirement for genetic screening to proactively reduce mortality rates from genetic disorders. A gene panel is a group of genes. It is examined collectively to identify genetic variations associated with conditions or disorders. These tools are employed in illness research, modified medicine, and genetic condition diagnostic testing.

• According to the Centers for Disease Control and Prevention (CDC), in 2023, about 5.2 million genomic sequencing tests were performed in the U.S.

These testing tools are performing analysis of the likelihood of multiple genes for cancer-associated mutations. They are used for treatments of diseases for instance cancer, syndrome-specific disorders, and any random infections. This test is considered as the most reliable test for investigative purposes than any BRCA1/2 genetics test.

Gene Panel Market Driver

Rising Occurrence of Genetic Disorder and Cancer and Growing Demand for Personalized Medicine Boost Market Growth

The growing factor for market expansion is the rising rate of incidence of genetic disorders among people. These hereditary diseases and various cancers are required to be diagnosed and treated. Therefore, it is impelling demand for the tools. In addition, governments from various regions are taking initiatives and investing in genomic research. Impositions of regulatory standards are pushing market growth.

• According to the National Institutes of Health (NIH), approximately USD 75 million was funded by the U.S. for gene panel research in 2023.

Furthermore, constant shifting towards personalized medicines for treatment of individuals is boosting market growth. It is allowing individuals to use the tool for identifying genetic mutation and adapt appropriate therapy. In addition, rising advancements in genomic technologies are boosting demand for the tools. This advancement is offering innovations in bioinformatics and (NGS). It augments the effectiveness and precision of the testing system, which is a more accessible and reliable system.

Gene Panel Market Restraint

High Cost of Sequencing Technologies and Data Privacy and Ethical Concerns Impede Market Growth

The off-putting factor that hinders market growth is the requirement for huge initial investment for the tools. Deployment of sequencing technology is increasing the charge of the tool as sequencing itself is expensive. This restricting accessibility for low-resource settings is deterring small scale firms from adoption of the solution. Additionally, non-compliance with reimbursement policies for genetic testing is hampering demand for the product. It is posing a barrier for healthcare providers as well as patience from using the product.

Furthermore, rising concerns regarding data privacy and ethical concerns among end-users are hindering market growth. Handling sensitive information of individuals and other data that are prone to breaching are affecting adoption rate. Moreover, shortages of skilled professionals who are trained in genomic data interpretation obstruct market growth.

Gene Panel Market Opportunity

Integration of AI and Expansion of Emerging Markets Create Opportunity for Market Growth

One of the significant opportunities for market growth is the incorporation of artificial intelligence into the method. It provides predictive analytics and enhanced accuracy of diagnostic work and personalized healing plans. In addition, development of customized systems is attracting new customers. Through customization, the market may cater to particular populations or disease, which may enhance effectiveness and relevance of the product.

Furthermore, development of emerging markets in developing countries is pushing market growth. They present new avenues for market expansion due to rising funds for research and healthcare facility improvement by the governments. In addition, acceptance of prenatal and neonatal screening is fostering market growth. Employment of the system for early-life screening for early intervention and management of diseases are attracting numerous customers.

• According to the Department of Biotechnology, FDA approved about 6 gene panel assays in India in 2023.

Segmentation

Key Insights

The report covers the following key insights:

• Rising Prevalence of Genetic Disorders and Cancer by Key Countries
• Integration with Artificial Intelligence with the Kits by Key Companies
• Drivers, Restraints, Trends, and Opportunities
• Business Strategies Adopted by Key Players
• Consolidated SWOT Analysis of Key Players
• Key Industry Developments (Mergers, Acquisitions, Partnerships)

Analysis by Type

Based on type, the gene panel market is divided into services and products.

The products segment is dominating in the region, driven by rising inclination towards self-utilitarianism among the population. Implementation of advanced test solutions is boosting segment growth.

The services segment is anticipated to grow in the market due to it offers a diverse array of tests for informing health decisions. It serves various tasks such as disease diagnosis, disease risk prediction, gene mutation identification, and treatment strategy guidance.

Analysis by Technology

Based on technology, the gene panel market is divided into amplicon sequencing and hybridization capture.

The amplicon sequencing segment is leading in the market, caused by its extensive utilization as a target-based next-generation sequencing technique. It is extensively used in numerous applications such as CRISP validation, detection of indels, and others.

The hybridization capture segment is estimated to grow in the market owing to its utilization in multigene panels and it is reproducible as well as reliable techniques. This method handles a large number of genes.

Analysis by Application

Based on application, the gene panel market is divided into neurology, oncology, cardiology, and others.

The oncology segment is leading in the region, caused by employment of these kits for cancer risk assessment. It diagnoses several cancers and offers personalized treatments.

The other segment is gaining traction such as congenital disease in the market due to exploitation of the system for diagnosing genetic conditions present at birth. The tool helps in screening individuals for a range of diseases such as cardiovascular, neonatal diabetes, and others.

Analysis by End User

Based on end user, the gene panel market is divided into pharma and biotech companies, research and academic institutes, and others.

The research and academic institutes segment is dominating in the market. It is driven by increasing cancer and genetic disorder incidence. Rising focus on prevention is pushing demand for the segment to perform R&D activities.

The pharma and biotech companies segment is anticipated to expand due to high spending by governments and embracing advanced drug development.

Regional Analysis

Based on geography, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

To gain extensive insights into the market, Download for Customization

North America is the leading region in the market. It is driven by the existence of advanced healthcare infrastructure. Furthermore, rising expenditure of huge amounts by the government for research and study activities are fostering market growth. Escalating high acceptance of genomic technologies is fueling demand for the solution and is boosting market expansion.

Europe is seeing substantial market growth, caused by rising robust R&D activities by several organizations. In addition, rising rates of incidence of genetic disorder among the population in this region are pushing demand for the kits and propelling market growth. Imposition of regulatory frameworks by the government is pushing manufacturers to produce innovative solutions.

The Asia Pacific region is expected to be the fastest-growing in the market from 2024 to 2033. Growing government initiatives are endorsing genomic research. These initiations are raising demand for the tools. Increasing spending on improving healthcare facilities is fostering market growth. Increasing awareness of genetic testing among the public is pushing demand for the system.

Key Players Covered

The report includes the profiles of the following key players:

• Paragon Genomics, Inc. (U.S.)
• Labcorp (U.S.)
• Celemics, Inc. (South Korea)
• Integrated DNA Technologies, Inc. (U.S.)
• GenScript (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• GENEWIZ (U.S.)
• Novogene Co., Ltd. (China)
• QIAGEN (Germany)

Key Industry Developments

• In August 2024, Illumina announced a joint venture with the Broad Institute to compose innovative gene sequencing kits through CRISPR technology to augment large-scale gene sequencing capabilities.
• In May 2024, 10x Genomics launched the 5,000-Plex Gene Panel for its Xenium platform, designed to propose advanced tissue biology and disease research and facilitate researchers to evaluate thousands of genes at the same time.
• In May 2023, Vizgen unveiled the MERFISH PanCancer Pathways Panel, a customizable gene panel to cater the spatial genomics applications in cancer research and provides enhanced error robustness and reproducibility.